IBB icon

iShares Biotechnology ETF

898 hedge funds and large institutions have $5.97B invested in iShares Biotechnology ETF in 2022 Q4 according to their latest regulatory filings, with 139 funds opening new positions, 257 increasing their positions, 288 reducing their positions, and 44 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

3.65% more ownership

Funds ownership: 61.6%65.25% (+3.6%)

11% less repeat investments, than reductions

Existing positions increased: 257 | Existing positions reduced: 288

36% less call options, than puts

Call options by funds: $325M | Put options by funds: $511M

Holders
898
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
22
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$325M
Puts
$511M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
226
$1.86M
227
$1.86M
228
$1.84M
229
$1.83M
230
$1.81M
231
$1.8M
232
$1.79M
233
$1.78M
234
$1.77M
235
$1.74M
236
$1.74M
237
$1.73M
238
$1.7M
239
$1.7M
240
$1.7M
241
$1.69M
242
$1.69M
243
$1.67M
244
$1.67M
245
$1.66M
246
$1.65M
247
$1.65M
248
$1.65M
249
$1.62M
250
$1.62M